CANNABIS TESTING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Global Cannabis Testing Market Size and Forecast 2026- 2033

Global cannabis testing market size is estimated at USD 3.35 Bn in 2026 and is expected to reach USD 10.11 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 17.1% from 2026 to 2033.

Key Takeaways of the Global Cannabis Testing Market

• In terms of product type, analytical instruments segment is estimated to contribute the highest market share of 46.5% in 2026.
• Potency testing segment is expected to be the dominating service type, with an estimated share of 26.5% in 2026.
• North America is projected to be the leading region in the global cannabis testing market, with an expected share of 40. 8% in 2026.

Market Overview

The global cannabis testing market is experiencing robust growth driven by regulatory evolution, technological innovation, and increasing demand for product safety. North America dominates revenue generation, accounting for the largest market share due to mature legal frameworks and commercial cannabis adoption. 

Current Events and Their Impact on the Global Cannabis Testing Market

Manufacturing facilities

• Thermo Fisher Scientific is a major supplier for cannabis testing that offers crucial analytical equipment like chromatography and spectroscopy systems. Their manufacturing plants in Waltham (U.S.), Bremen (Germany), and Shanghai (China) operate at a large scale. They generate thousands of these instruments and testing kits annually.
• Agilent Technologies has specialized manufacturing sites in Santa Clara (U.S.), Waldbronn (Germany), and Shanghai (China). These facilities primarily produce high-performance liquid chromatography (HPLC) instruments and gas chromatography-mass spectrometry (GC-MS) systems. Agilent's combined annual production capacity for these analytical instruments is estimated to be over several thousand units.

Emerging Applications in the Global Cannabis Testing Market

An emerging and largely untapped application within the cannabis testing market is the comprehensive genetic or DNA-based cannabis testing. For instance, Medicinal Genomics, a biotechnology company, introduced technology enabling cannabis cultivators and processors to screen for harmful pathogens, potency prediction, and strain authenticity using genetic sequencing methods.

Market Trends 

Increasing Legalization and Regulatory Compliance

The cannabis testing market is experiencing growth due to increasing legalization and the implementation of regulatory requirements across various regions. Neotron, an Italy-based ISO-accredited laboratory, provides a comprehensive portfolio of cannabis testing services aligned with both national and European pharmaceutical standards.

The global cannabis operators require the EU-GMP certification to get access in the European market. The Cannabis Reform Law passed in April 2024 has removed restrictions on domestic producers in Germany. However, in 2024, Germany has imported over 72 tons of cannabis. This highlights that imported cannabis is expected to remain dominant for years to come.

Technological Advancements and Service Innovations

Technological advancements in analytical instruments like chromatography and mass spectrometry are enhancing testing accuracy and efficiency. The adoption of Laboratory Information Management Systems (LIMS) is streamlining workflows.

Creative service models, such as mobile and on-site testing, are emerging to cater to diverse industry needs. Moreover, the development of rapid testing methods and user-friendly kits is increasing accessibility. These service and technological innovations are contributing to a more efficient cannabis testing ecosystem.

In May 2023, Trichome Analytical, a U.S.-based laboratory, announced the licensing of PhytoFacts. It is a cannabis analytical data tool. Through this tool, Trichome aims to provide clients with a comprehensive profile and deeper insights into the cannabis they test.

Market Opportunity: Emergence of new testing methods

The emergence of new testing methods can offer growth opportunity for global cannabis testing market. The Advanced analytical techniques allow for more comprehensive product quality screening than ever before. Technological advancements in testing methods, including chromatography and spectroscopy, are enhancing efficiency and accuracy, creating opportunities for innovation in testing services and equipment.

In 2024, Agilent Technologies introduced its next-generation InfinityLab LC Series portfolio, representing a significant advancement in liquid chromatography technology for various applications, including cannabis testing.

Segmental Analysis

Service Type-Based Insights into the Global Cannabis Testing Market

In terms of service type, potency testing segment is estimated to contribute the highest market share of 25.5% in 2025, owing to strict regulations.

As the legal cannabis market expand worldwide, ensuring product safety and consistency becomes crucial. Potency testing determines the amount or concentration of THC, CBD, and other cannabinoids in a sample. Precise potency measurements are important for compliance with legal limits and for manufacturers to develop accurate dosage formulations.

Global Cannabis Testing Market Analysis by Product Type – Trends, Growth, and Forecast

In terms of product type, analytical instruments segment is estimated to contribute the highest market share of 45.5% in 2025, due to rising complexity of product formulations.

Analytical instruments offer the selectivity and precision that are needed to test novel product formulations as businesses expand into new categories. This analytical capability allows for consistent manufacturing of advanced goods. For instance, in 2023, Shimadzu Corporation, a Japan-based company, launched Brevis GC 2050 gas chromatograph. This chromatograph is used for cannabis testing.

Cannabis Testing Market by End User: Insights and Growth Opportunities for Drug Manufacturers

In terms of end user, cannabis drug manufacturers segment is estimated to contribute the highest market share of 52.5% in 2026, owing to stringent regulatory requirements.

 Manufacturers face strict guidelines by health agencies when developing and producing cannabis-based medicines, edibles, extracts and other consumer goods. Failing product tests can lead to costly waste disposal, damage to brand reputation, and in severe cases regulatory non-compliance penalties. Comprehensive testing smoothens new product approvals and regulates interstate commerce activities.

Regional Insights

 North America Cannabis Testing Industry Trends and Analysis

North America has been the dominant region in the global cannabis testing market with an estimated market share of 40.8% in 2026, primarily due to legalization of both medical and recreational marijuana in major markets like the U.S. and Canada. Countries in this region have made meaningful investments in building a strong testing infrastructure to ensure product safety and quality.

Asia Pacific Cannabis Testing Industry Report

The cannabis testing market in the Asia Pacific region is gaining momentum as more countries, such as Australia and Thailand, legalize medical use. This growing acceptance is driving a greater need for thorough testing to guarantee product safety for patients. The growing demand for dependable and safe cannabis products is creating substantial avenues for expansion within the Asia Pacific testing industry.

U.S. Cannabis Testing Market Trends and Analysis

U.S. Cannabis Testing Market is expected to exhibit a CAGR of 10.5% during the forecast period. The West Coast, especially California, Oregon, and Colorado, remains the most mature market due to early legalization and high production volumes.

China Cannabis Testing Market Trends and Analysis

China’s cannabis testing market is marked by rapid expansion, driven by advancements in testing technologies and a gradually evolving regulatory framework. The market presents substantial growth opportunities, particularly in industrial hemp testing. However, challenges remain, including strict government oversight, lack of standardized testing protocols, and high barriers to entry for foreign and private laboratories.

Market Report Scope

Global Cannabis Testing Industry News

• In March 2025, Kaycha Labs was awarded a new contract by the Massachusetts Cannabis Control Commission (CCC) to serve as an official testing laboratory for cannabis in Massachusetts, U.S.
• In February 2025, ASTM International published a new standard which focused on ensuring the consistency and uniformity of cannabis-infused products. This standard provides guidelines for manufacturers on quality control measures and helps to enhance consumer confidence and product reliability across the industry.
• In February 2024, The Bank of Guam in the U.S. launched Cannabis Banking. This program provides banking services for the cannabis industry on Guam and the Commonwealth of the Northern Mariana Islands.
• In January 2024, Smithers relocated its Cannabis Testing Services division to a new, state-of-the-art laboratory in Darien, U.S. This move, situated outside of Chicago, reflects Smithers' commitment to the cannabis industry by improving client proximity, optimizing sampling routes, and investing in advanced technology.

Analyst View

• Increasing legalization of cannabis globally is a major role in market development. Strict regulations mandating safety and potency testing further fuel this demand.
• Significant upfront capital investment poses a barrier for smaller testing labs. The absence of consistent testing standards across regions creates operational challenges.
• Regionally, North America is currently dominating the cannabis testing market, particularly the U.S. However, evolving regulations in Europe and Latin America present substantial future growth potential.

Market Segments

•  Service Type Insights (Revenue, USD Bn, 2020 - 2032)
• Potency Testing
• Residual Solvent Testing
• Mycotoxin Testing
• Microbial Testing
• Genetic Testing
• Heavy Metal Testing
• Pesticide Screening
• Others
•  Product Type Insights (Revenue, USD Bn, 2020 - 2032)
• Analytical Instruments
• Chromatography
• Spectroscopy
• Consumables Testing Software & Services
• Breathe Analyzer
•  End User Insights (Revenue, USD Bn, 2020 - 2032)
• Cannabis Drug Manufacturers
• Cannabis Cultivators/Growers
• Research Institutes & Labs
• Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Anresco
• SC Labs, Inc
• CW Analytical Laboratories
• Digipath, Inc
• EVIO, Inc
• Eurofins Scientific
• Pure Analytics LLC
• Green Scientific Labs
• Steep Hills, Inc
• PharmLabs
• Agilent Technologies Inc.
• Shimadzu Scientific Instruments
• Restek Corporation
• PerkinElmer Inc.
• Danaher Corporation
• Accelerated Technology Laboratories Inc.
• Sartorius AG

Sources

Stakeholders:

• Cannabis Testing Laboratories
• Cannabis Cultivators and Producers
• Cannabis Product Distributors
• Regulatory Authorities and Policymakers
• Others

 Databases:

• ScienceDirect
• ClinicalTrials.gov
• Others

 Magazines:

• Cannabis Industry Journal
• Marijuana Business Magazine
• Analytical Cannabis Magazine
• Others

Journals:

• Journal of Cannabis Research
• Cannabis and Cannabinoid Research
• Journal of Analytical Toxicology
• Others

 Newspapers:

• The Wall Street Journal
• The New York Times
• Cannabis Business Times
• Others

Associations:

• Association of Commercial Cannabis Laboratories (ACCL)
• National Cannabis Industry Association (NCIA)
• American Herbal Products Association (AHPA)
• ASTM Cannabis Committee (ASTM D37)
• Others

Public Domain sources:

• World Health Organization (WHO)
• U.S. Food and Drug Administration (FDA)
• Health Canada
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
• Others

 Proprietary Elements:

• CMI Data Analytics Tool, Proprietary CMI Existing Repository of information for last 8 years

*Definition: Global Cannabis Testing Market involves the testing of cannabis and cannabis-derived products for various quality parameters like potency, pesticides, residual solvents, bacteria and other contaminants. This market includes testing for both medical and recreational cannabis to ensure product safety and compliance with regulations. The testing helps produce high quality and consistent cannabis and cannabis products while protecting consumer health. Various testing methods are used like chromatography testing, potency testing and terpene profiling. The market is evolving with the legalization of medical and recreational cannabis in many countries.